Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Dispatch

Rifampicin Resistance in Tuberculosis Outbreak, London, England

Claire Jenkins*Comments to Author , Alleyna P. Claxton†, Robert J. Shorten*, Timothy D. McHugh*, and Stephen H. Gillespie*
Author affiliations: *Royal Free Hospital, London, United Kingdom; †Homerton Hospital, London, United Kingdom

Main Article

Table

Sequences of 6 sets of primers designed to amplify 6 overlapping fragments of the rpoB gene from Mycobacterium tuberculosis isolates

Fragment Amplicon size Primer position Primers
1 697 bp –135 to –112*
541–562 Forward 5´ GTT TAG TTG CGT GCG TGC
Reverse 5´ CTTGTCAAT GGT CTC GTC GAA
2 688 bp 451–472
1119–1139 Forward 5´ TTC CCG ATG ATG ACC GAG AAG
Reverse 5´ GGA TCA GCT CGC CGA CCG TA
3 706 bp 1029–1048
1714–1735 Forward 5´ CGA GGG TCA GAC CAC GAT G
Reverse 5´ GCG GGG CGA GAC GTC CAT GTA
4 681 bp 1624–1645
2284–2305 Forward 5´ ATC GAT GCG GAC GGT CGC TTC
Reverse 5´ CGG GAT GTC GCG GGT GAT CTC
5 811 bp 2194–2215
2887–3005 Forward 5´ TCC AAC CGC CTG GTC GAA GAG
Reverse 5´ CGT CGA CAC AAT GGC GTT
6 847 bp 2797–2815
+113 to +135* Forward 5´ TGT GCC CAC AGC GGC TGG
Reverse 5´ CTT TTT GAC CTC GCC ATA GGA C

*Denotes a primer position in the sequence before the start (–) or after the end (+) of the rpoB gene sequence.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external